Works matching IS 15272729 AND DT 2023 AND VI 24 AND IP 4
Results: 9
Not All Leiomyosarcomas Are the Same: How to Best Classify LMS.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 4, p. 327, doi. 10.1007/s11864-023-01067-2
- By:
- Publication type:
- Article
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 4, p. 373, doi. 10.1007/s11864-023-01065-4
- By:
- Publication type:
- Article
Myxoid Liposarcoma: How to Stage and Follow.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 4, p. 292, doi. 10.1007/s11864-023-01064-5
- By:
- Publication type:
- Article
Gene Mutations and Targeted Therapies of Myeloid Sarcoma.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 4, p. 338, doi. 10.1007/s11864-023-01063-6
- By:
- Publication type:
- Article
Integrating Palliative Care into Oncology Care Worldwide: The Right Care in the Right Place at the Right Time.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 4, p. 353, doi. 10.1007/s11864-023-01060-9
- By:
- Publication type:
- Article
Progress in the Treatment of Small Intestine Cancer.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 4, p. 241, doi. 10.1007/s11864-023-01058-3
- By:
- Publication type:
- Article
Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 4, p. 300, doi. 10.1007/s11864-023-01059-2
- By:
- Publication type:
- Article
Myxoid Liposarcomas: Systemic Treatment Options.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 4, p. 274, doi. 10.1007/s11864-023-01057-4
- By:
- Publication type:
- Article
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 4, p. 262, doi. 10.1007/s11864-023-01055-6
- By:
- Publication type:
- Article